POSTN and neoplasm: We have shown that the tumour-promoting and chemoprotective properties of CAFs are associated with an activated myofibroblast (α-Smooth Muscle Actin/ACTA2+, Periostin/POSTN+) phenotype that can be reversed with phosphodiesterase type 5 inhibitors (PDE5i) [8].